Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome:

Irene Battel, Isabella Koch, Federica Biddau, Carla Carollo, Francesco Piccione, Francesca Meneghello, Antonio Merico, Katie Palmer, Rosario Marchese-Ragona

Research output: Contribution to journalArticle

12 Downloads (Pure)

Abstract

BACKGROUND: Wallenberg’s syndrome (WS) is known as posterior inferior cerebellar artery syndrome. Dysphagia has been reported from 51% to 94% of the patients, ranging from mild to severe.
CASE REPORT: We reported a case of a patient (male; 52 years) with WS. MRI showed an intense hypodense area in the dorsolateral part of the ponto-medullary junction. The clinical signs were severe dysphagia, fed by PEG (FOIS 1; PAS 7), sialorrhea, trismus and ataxia.
CLINICAL REHABILITATION IMPACT: Dysphagia was treated by botulinum toxin type-A (BoNT-A), which was injected into the parotid and submandibular salivary glands, temporalis and masseter muscles, cricopharyngeal muscle associated with specific swallowing exercise and food trails. The 3-months follow-up showed significant saliva reduction and improvement of swallowing to from PEG feeding to consistent oral intake of food (FOIS 3, PAS 5). The treatment with BoNT-A combined with swallowing rehabilitation was fundamental in order to restore the swallowing functions.

KEY WORDS: Lateral medullary syndrome - Botulinum toxins, type A - Deglutition disorders - Sialorrhea
Original languageItalian
Pages (from-to)798-801
Number of pages4
JournalEuropean Journal of Physical and Rehabilitation Medicine
Volume53
Issue number(5)
Publication statusPublished - Oct 7 2017

Cite this

Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome: / Battel, Irene; Koch, Isabella; Biddau, Federica ; Carollo, Carla ; Piccione, Francesco; Meneghello, Francesca; Merico, Antonio; Palmer, Katie; Marchese-Ragona, Rosario.

In: European Journal of Physical and Rehabilitation Medicine, Vol. 53, No. (5), 07.10.2017, p. 798-801.

Research output: Contribution to journalArticle

@article{62b672f86a424572a1d9aa899b3fc50c,
title = "Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome:",
abstract = "BACKGROUND: Wallenberg’s syndrome (WS) is known as posterior inferior cerebellar artery syndrome. Dysphagia has been reported from 51{\%} to 94{\%} of the patients, ranging from mild to severe.CASE REPORT: We reported a case of a patient (male; 52 years) with WS. MRI showed an intense hypodense area in the dorsolateral part of the ponto-medullary junction. The clinical signs were severe dysphagia, fed by PEG (FOIS 1; PAS 7), sialorrhea, trismus and ataxia.CLINICAL REHABILITATION IMPACT: Dysphagia was treated by botulinum toxin type-A (BoNT-A), which was injected into the parotid and submandibular salivary glands, temporalis and masseter muscles, cricopharyngeal muscle associated with specific swallowing exercise and food trails. The 3-months follow-up showed significant saliva reduction and improvement of swallowing to from PEG feeding to consistent oral intake of food (FOIS 3, PAS 5). The treatment with BoNT-A combined with swallowing rehabilitation was fundamental in order to restore the swallowing functions.KEY WORDS: Lateral medullary syndrome - Botulinum toxins, type A - Deglutition disorders - Sialorrhea",
author = "Irene Battel and Isabella Koch and Federica Biddau and Carla Carollo and Francesco Piccione and Francesca Meneghello and Antonio Merico and Katie Palmer and Rosario Marchese-Ragona",
year = "2017",
month = "10",
day = "7",
language = "Italian",
volume = "53",
pages = "798--801",
journal = "European Journal of Physical and Rehabilitation Medicine",
issn = "1973-9087",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "(5)",

}

TY - JOUR

T1 - Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome:

AU - Battel, Irene

AU - Koch, Isabella

AU - Biddau, Federica

AU - Carollo, Carla

AU - Piccione, Francesco

AU - Meneghello, Francesca

AU - Merico, Antonio

AU - Palmer, Katie

AU - Marchese-Ragona, Rosario

PY - 2017/10/7

Y1 - 2017/10/7

N2 - BACKGROUND: Wallenberg’s syndrome (WS) is known as posterior inferior cerebellar artery syndrome. Dysphagia has been reported from 51% to 94% of the patients, ranging from mild to severe.CASE REPORT: We reported a case of a patient (male; 52 years) with WS. MRI showed an intense hypodense area in the dorsolateral part of the ponto-medullary junction. The clinical signs were severe dysphagia, fed by PEG (FOIS 1; PAS 7), sialorrhea, trismus and ataxia.CLINICAL REHABILITATION IMPACT: Dysphagia was treated by botulinum toxin type-A (BoNT-A), which was injected into the parotid and submandibular salivary glands, temporalis and masseter muscles, cricopharyngeal muscle associated with specific swallowing exercise and food trails. The 3-months follow-up showed significant saliva reduction and improvement of swallowing to from PEG feeding to consistent oral intake of food (FOIS 3, PAS 5). The treatment with BoNT-A combined with swallowing rehabilitation was fundamental in order to restore the swallowing functions.KEY WORDS: Lateral medullary syndrome - Botulinum toxins, type A - Deglutition disorders - Sialorrhea

AB - BACKGROUND: Wallenberg’s syndrome (WS) is known as posterior inferior cerebellar artery syndrome. Dysphagia has been reported from 51% to 94% of the patients, ranging from mild to severe.CASE REPORT: We reported a case of a patient (male; 52 years) with WS. MRI showed an intense hypodense area in the dorsolateral part of the ponto-medullary junction. The clinical signs were severe dysphagia, fed by PEG (FOIS 1; PAS 7), sialorrhea, trismus and ataxia.CLINICAL REHABILITATION IMPACT: Dysphagia was treated by botulinum toxin type-A (BoNT-A), which was injected into the parotid and submandibular salivary glands, temporalis and masseter muscles, cricopharyngeal muscle associated with specific swallowing exercise and food trails. The 3-months follow-up showed significant saliva reduction and improvement of swallowing to from PEG feeding to consistent oral intake of food (FOIS 3, PAS 5). The treatment with BoNT-A combined with swallowing rehabilitation was fundamental in order to restore the swallowing functions.KEY WORDS: Lateral medullary syndrome - Botulinum toxins, type A - Deglutition disorders - Sialorrhea

UR - https://www.minervamedica.it/it/riviste/europa-medicophysica/articolo.php?cod=R33Y2017N05A0798

M3 - Articolo

VL - 53

SP - 798

EP - 801

JO - European Journal of Physical and Rehabilitation Medicine

JF - European Journal of Physical and Rehabilitation Medicine

SN - 1973-9087

IS - (5)

ER -